UNIVERSITY OF VIRGINIA
BOARD OF VISITORS
MEETING ON BUSINESS MATTERS
AUGUST 17, 2015
BOARD MEETING ON BUSINESS MATTERS
Monday, August 17, 2015
8:30 – 9:30 a.m.
Forum Room, Miller Center
AGENDA
PAGE
I.
II.
III.
ACTION ITEMS (Mr. Goodwin)
A. Proposed Legislation (President Sullivan)
B. Faculty Representative to the Board
1
10
DISCUSSION ITEM (Mr. Goodwin)

Committee Structure
11
ATTACHMENTS
A. Chart: Proposal to Reorganize Committee Structure
B. Board Committee Charges – Proposal
C. Code of Virginia § 23-9.2:4.1 on Faculty
Representatives
UNIVERSITY OF VIRGINIA
BOARD OF VISITORS AGENDA ITEM SUMMARY
BOARD MEETING:
August 17, 2014
COMMITTEE:
Full Board
AGENDA ITEM:
I.A. Proposed Legislation: Amending the
Code of Virginia to provide institutional
review boards greater flexibility in the
oversight of certain human subject research
BACKGROUND: Currently, human subject research funded and/or
regulated by a federal agency is governed by federal
regulations, and institutions that conduct federally-funded
research must accept the terms of a federal wide assurance (FWA)
in which they commit to comply with the requirements in the
Department of Health and Human Services’ (DHHS) Protection of
Human Subjects regulations, also known as the Common Rule.
Until recently, it had been common practice, but not a
requirement, for institutions, including the University, to
voluntarily extend the FWA, and thus the requirements of the
Common Rule, to all research regardless of the funding source.
In an effort to provide greater flexibility in the
oversight of non-federally-funded research and to avoid various
administrative burdens associated with the Common Rule,
institutions in other states have changed their practices and no
longer extend the FWA to non-federally funded research. Current
law in Virginia, however, includes provisions for human subject
research to which institutions are subject if they do not follow
federal regulations. Some existing provisions in the Code of
Virginia impose greater restrictions than federal regulations,
while others differ only slightly.
In an effort to increase efficiency and reduce unnecessary
administrative requirements, the University proposes amending
the provisions in the Code of Virginia relating to human subject
research to grant greater flexibility in the oversight of
research that is not funded or regulated by a federal agency.
The proposed changes will allow institutional review boards
(IRBs) in Virginia to streamline processes for non-federally
funded, low-risk human subject research and will reduce the time
dedicated to administering and processing low-risk research.
This will in-turn provide IRBs additional time to dedicate to
higher-risk research. Because the proposed legislation will
have an impact on human subject IRBs across the Commonwealth,
1
the Office of the Vice President for Research has discussed the
University’s proposal with IRB personnel at several other
institutions, and has received their support.
DISCUSSION: The University seeks to introduce legislation for
consideration during the 2016 Session of the General Assembly to
amend §§ 32.1-162.16 through 32.1-162.19 of the Code of Virginia
to provide institutional review boards greater flexibility in
the oversight of non-federally funded, low-risk human subject
research. The proposed amendments are underlined in the body of
the resolution.
ACTION REQUIRED:
Approval by the Board of Visitors
LEGISLATIVE PROPOSAL TO AMEND CODE OF VIRGINIA SECTIONS 32.1162.16 through and 32.1-162.19
RESOLVED, the Board of Visitors approves and endorses
amending the Code of Virginia as it pertains to research with
human subjects.
The proposed amendments to §§ 32.1-162.16 through 32.1162.19 of the Code of Virginia are as follows:
§ 32.1-162.16. Definitions.
As used in this chapter, unless the context requires a different
meaning:
"Human research" means any systematic investigation, including
research development, testing and evaluation, utilizing human
subjects, that is designed to develop or contribute to
generalized knowledge. Human research shall not be deemed to
include research exempt from federal research regulation
pursuant to 45 C.F.R. § 46.101(b).
“Human subject” means a living individual about whom an
investigator (whether profession or student) conducting research
obtains data through intervention or interaction with the
individual, or identifiable private information.
"Informed consent" means the knowing and voluntary agreement,
without undue inducement or any element of force, fraud, deceit,
duress, or other form of constraint or coercion, of a person who
is capable of exercising free power of choice. For the purposes
of human research, the basic elements of information necessary
to such consent shall include:
2
1. A reasonable and comprehensible explanation to the person of
the proposed procedures or protocols to be followed, their
purposes, including descriptions of any attendant discomforts,
and risks and benefits reasonably to be expected;
2. A disclosure of any appropriate alternative procedures or
therapies that might be advantageous for the person, if
applicable;
3. An instruction that the person may withdraw his consent and
discontinue participation in the human research at any time
without prejudice to him;
4. An explanation of any costs or compensation which may accrue
to the person and, if applicable, the availability of third
party reimbursement for the proposed procedures or protocols;
and
5. An offer to answer and answers to any inquiries by the person
concerning the procedures and protocols.
"Institution" or "agency" means any facility, program, or
organization owned or operated by the Commonwealth, by any
political subdivision, or by any person, firm, corporation,
association, or other legal entity.
"Legally authorized representative" means, in the following
specified order of priority, (i) the parent or parents having
custody of a prospective subject who is a minor, (ii) the agent
appointed under an advance directive, as defined in § 54.1-2982,
executed by the prospective subject, provided the advance
directive authorizes the agent to make decisions regarding the
prospective subject's participation in human research, (iii) the
legal guardian of a prospective subject, (iv) the spouse of the
prospective subject, except where a suit for divorce has been
filed and the divorce decree is not yet final, (v) an adult
child of the prospective subject, (vi) a parent of the
prospective subject when the subject is an adult, (vii) an adult
brother or sister of the prospective subject or (viii) any
person or judicial or other body authorized by law or regulation
to consent on behalf of a prospective subject to such subject's
participation in the particular human research. For the purposes
of this chapter, any person authorized by law or regulation to
consent on behalf of a prospective subject to such subject's
participation in the particular human research shall include an
attorney in fact appointed under a durable power of attorney, to
the extent the power grants the authority to make such a
3
decision. The attorney in fact shall not be employed by the
person, institution, or agency conducting the human research. No
official or employee of the institution or agency conducting or
authorizing No person directly involved in the conduct or
approval of the research shall be qualified to act as a legally
authorized representative.
"Minimal risk" means that the risks of harm anticipated in the
proposed research are not greater, considering probability and
magnitude, than those ordinarily encountered in daily life or
during the performance of routine physical or psychological
examinations or tests.
"Nontherapeutic research" means human research in which there is
no reasonable expectation of direct benefit to the physical or
mental condition of the human subject.
§ 32.1-162.17. Exemptions.
The following categories of human research are exempt from the
provisions of this chapter:
1. Activities of the Virginia Department of Health conducted
pursuant to § 32.1-39;
2. Research or student learning outcomes assessments conducted
in educational settings involving regular or special education
instructional strategies, the effectiveness of or the comparison
among instructional techniques, curricula, or classroom
management methods, or the use of educational tests, whether
cognitive, diagnostic, aptitude, or achievement, if the data
from such tests are recorded in a manner so that subjects cannot
be directly identified, directly or through identifiers linked
to the subjects;
3. Research involving survey or interview procedures that
involves no procedures which place the subject at risk for
physical or psychological harm, and only involves non-invasive
activities, survey, interview or focus group procedures, unless
responses are recorded in such a manner that the subjects can be
identified, directly or through identifiers linked to the
subjects, and either (i) the subject's responses, if they became
known outside the research, could reasonably place the subject
at risk of criminal or civil liability or be damaging to the
subject's financial standing or employability or (ii) the
research deals with sensitive aspects of the subject's own
behavior, such as sexual behavior, drug or alcohol use, or
illegal conduct;
4
4. Research involving survey or interview procedures, when the
respondents are elected or appointed public officials or
candidates for public office;
5. Research involving solely the observation of public behavior,
including observation by participants, unless observations are
recorded in such a manner that the subjects can be identified,
directly or through identifiers linked to the subjects, and
either (i) the observations recorded about the individual, if
they became known outside the research, could reasonably place
the subject at risk of criminal or civil liability or be
damaging to the subject's financial standing or employability or
(ii) the research deals with sensitive aspects of the subject's
own behavior, such as sexual behavior, drug or alcohol use, or
illegal conduct; and
6. Research involving the collection or study of existing data,
documents, records, pathological specimens, or diagnostic
specimens, (i) if these sources are publicly available or if;
(ii) if the information is recorded by the investigator in a
manner so that subjects cannot be identified, directly or
through identifiers linked to the subjects; or (iii) if the
information is recorded in a manner so that the subjects could
be identified, the information is protected from disclosure
through required compliance with applicable institutional
policies, state statutes, and federal regulations that mandate
security provisions to protect the confidentiality of the
information.
§ 32.1-162.18. Informed consent.
A. In order to conduct human research in this Commonwealth,
informed consent must be obtained if the person who is to be the
human subject is as follows: (i) capable of making an informed
decision, then it shall be subscribed to in writing by the
person and witnessed; (ii) incapable of making an informed
decision, as defined in § 54.1-2982, at the time consent is
required, then it shall be subscribed to in writing by the
person's legally authorized representative and witnessed; or
(iii) a minor otherwise capable of rendering, then it shall be
subscribed to in writing by the minor’s legally authorized
representative, unless the minor is permitted to render informed
consent because of emancipated status under § 16.1-333 or deemed
adult status under § 54.1-2969, then it shall be subscribed to
in writing by both the minor and his legally authorized
representative. The giving of consent by a legally authorized
representative shall be subject to the provisions of subsection
5
B of this section. If two or more persons who qualify as legally
authorized representatives and have equal decision-making
priority under this chapter inform the principal investigator or
attending physician that they disagree as to participation of
the prospective subject in human research, the subject shall not
be enrolled in the human research that is the subject of the
consent. No informed consent form shall include any language
through which the person who is to be the human subject waives
or appears to waive any of his legal rights, including any
release of any individual, institution, or agency or any agents
thereof from liability for negligence.
Notwithstanding consent by a legally authorized representative,
no person shall be forced to participate in any human research
if the investigator conducting the human research knows that
participation in the research is protested by the prospective
subject. In the case of persons suffering from organic brain
diseases causing progressive deterioration of cognition for
which there is no known cure or medically accepted treatment,
the implementation of experimental courses of therapeutic
treatment to which a legally authorized representative has given
informed consent shall not constitute the use of force.
B. A legally authorized representative may not consent to
nontherapeutic research unless it is determined by the human
research committee that such nontherapeutic research will
present no more than a minor increase over minimal risk to the
human subject. A legally authorized representative may not
consent to participation in human research on behalf of a
prospective subject if the legally authorized representative
knows, or upon reasonable inquiry ought to know, that any aspect
of the human research protocol is contrary to the religious
beliefs or basic values of the prospective subject, whether
expressed orally or in writing. A legally authorized
representative may not consent to participation in human
research involving nontherapeutic sterilization, abortion,
psychosurgery or admission for research purposes to a facility
or hospital as defined in § 37.2-100.
C. Except as provided elsewhere in this chapter, no investigator
may involve a human being as a subject in research covered by
this chapter unless the investigator has obtained the legally
effective informed consent of the subject or the subject's
legally authorized representative. An investigator shall seek
such consent only under circumstances that provide the
prospective subject or the legally authorized representative
sufficient opportunity to consider whether or not to participate
6
and that minimize the possibility of coercion or undue
influence.
D. The human research review committee may approve a consent
procedure which omits or alters some or all of the basic
elements of informed consent, or waives the requirement to
obtain informed consent, if the committee finds and documents
that (i) the research involves no more than minimal risk to the
subjects; (ii) the omission, alteration or waiver will not
adversely affect the rights and welfare of the subjects; (iii)
the research could not practicably be performed without the
omission, alteration or waiver; and (iv) after participation,
the subjects are to be provided with additional pertinent
information, whenever appropriate.
E. The human research review committee may waive the requirement
that the investigator obtain written informed consent for some
or all subjects, (i) if the committee finds that the only record
linking the subject and the research would be the consent
document and the principal risk would be potential harm
resulting from a breach of confidentiality or (ii) that the
research presents no more than minimal risk of harm to subjects
and involves no procedures for which written consent is normally
required outside of the research context. The committee may
require the investigator to provide the subjects with a written
statement explaining the research. Further, each subject shall
be asked whether he wants documentation linking him to the
research and the subject's wishes shall govern.
§ 32.1-162.19. Human research review committees.
A. Each institution or agency which conducts or which proposes
to conduct or authorize a human research project shall establish
or designate a human research review committee to review the
project. The committee shall be composed of representatives of
varied backgrounds to ensure the competent, complete, and
professional review of human research activities conducted or
proposed to be conducted or authorized by the institution or
agency. No member of the committee shall be directly involved in
the proposed human research or have administrative approval
authority over the proposed human research except in connection
with his responsibilities as a member of the committee. No
committee may have a member participate in the committee’s
initial or continuing review of any project in which the member
has a conflicting interest, except to provide information
requested by the committee.
7
B. No human research shall be conducted or authorized by such
institution or agency unless the established or designated
committee has reviewed and approved the proposed human research
project giving consideration to (i) the adequacy of the
description of the potential benefits and risks involved and the
adequacy of the methodology of the research; (ii) if the
research is nontherapeutic, whether it presents more than a
minimal risk to the human subjects whether the risks to subjects
are reasonable in relation to anticipated benefits, if any, to
subjects, and the importance of the knowledge that may
reasonably be expected to result; (iii) whether the rights and
welfare of the human subjects involved are adequately protected;
(iv) whether the risks to the human subjects are outweighed by
the potential benefits to them; (v) whether the risks to
subjects are minimized by using procedures that are consistent
with sound research design and that do not unnecessarily expose
subjects to risk and, whenever appropriate, by using procedures
already being performed on the subjects for diagnostic or
treatment purposes; (vi) when some or all of the subjects are
likely to be incapable of making an informed decision regarding
consent or are otherwise vulnerable to coercion or undue
influence, such as children, prisoners, pregnant women, mentally
disabled persons, or economically or educationally disadvantaged
persons, whether additional safeguards have been included in the
study to protect the rights and welfare of these subjects; (vii)
whether the informed consent is to be obtained by methods that
are adequate and appropriate and whether the written consent
form is adequate and appropriate in both content and language
for the particular research; (viii) whether the persons
proposing to conduct the particular human research are
appropriately competent and qualified; and (ix) (viii) whether
the criteria for selection of subjects are equitable; and (ix)
whether there are adequate provisions to protect the privacy of
subjects and to maintain the confidentiality of data. The
committee shall require periodic reports from each existing
human research project to ensure that the project is being
carried out in conformity with the proposal as approved.
C. The regulations of an institution or agency may authorize the
committee to conduct an expedited review of a human research
project which involves no more than minimal risk to the subjects
if (i) another institution's or agency's human research review
committee has reviewed and approved the project or (ii) the
review involves only minor changes in a previously approved
research project that do not increase risks to subjects and the
changes occur during the approved project period or (ii) the
study is minimal risk and the procedures in the study satisfy
8
the criteria for expedited review as published in the Federal
Register by the Secretary of HHS.
D. Every person engaged in the conduct of human research or
proposing to conduct human research shall affiliate himself with
an institution or agency having a research review committee, and
the human research which he conducts or proposes to conduct
shall be subject to review and approval by such committee in the
manner set forth in this section. All human research conducted
in the Commonwealth shall be subject to review and approval by a
human research review committee as specified in this chapter.
E. Each human research review committee of a state institution
or agency shall ensure that an overview of approved human
research projects and the results of such projects are made
public on the institution's or agency's website unless otherwise
exempt from disclosure under the Virginia Freedom of Information
Act (§ 2.2-3700 et seq.).
9
UNIVERSITY OF VIRGINIA
BOARD OF VISITORS AGENDA ITEM SUMMARY
BOARD MEETING:
August 17, 2015
COMMITTEE:
Full Board
AGENDA ITEM:
I.B.
Faculty Representative to the Board
BACKGROUND: In 2007, the Board passed a resolution adding the
former chair of the Faculty Senate as a nonvoting member of
three Board committees: Educational Policy, Advancement and
Communications, and Diversity and Inclusion. The Medical Center
Operating Board also includes a nonvoting faculty member: the
president of the clinical staff, as well as the deans of the
School of Medicine and the School of Nursing. In the fall of
2012, the Board authorized the rector to add nonvoting faculty
members to the other standing committees.
DISCUSSION: At the March 2015 meeting, the Board adopted a
resolution stating that pursuant to § 23-9.2:4.1 of the Code of
Virginia, at the late spring meeting every year beginning in
2015 the Board of Visitors shall appoint a non-voting advisory
faculty representative to serve on the Board for a term of one
year, with a limit of two consecutive terms. The code language
referenced above can be found in Attachment C.
The Rector and Vice Rector recommend that the immediate
past chair of the Faculty Senate be designated the nonvoting
faculty representative for two primary reasons: the immediate
past chair has worked extensively with faculty constituents
across the institution, and he or she is familiar with the
operations of the Board of Visitors – the chair of the Faculty
Senate regularly attends and addresses the Board at every
regular meeting of the Board.
ACTION REQUIRED:
Approval by the Board of Visitors
FACULTY REPRESENTATIVE TO THE BOARD
RESOLVED, the immediate past chair of the Faculty Senate
shall serve as the nonvoting faculty advisory representative
to the Board of Visitors for one year terms commencing June 1
of each year.
10
UNIVERSITY OF VIRGINIA
BOARD OF VISITORS AGENDA ITEM SUMMARY
BOARD MEETING:
August 17, 2015
COMMITTEE:
Full Board
AGENDA ITEM:
II.
Committee Structure
BACKGROUND: Currently there are 10 standing committees plus two
special committees, for a total of 12 committees. By practice,
every committee meets at every regular meeting, requiring the
Board to spend most of their two days of meeting time in
committee meetings. Consolidating the functions of some
committees would allow for more time flexibility and more
continuity, with committee members gaining a broader
understanding of the University’s work in the committee
meetings.
The 10 standing committees are: Executive; Finance;
Buildings and Grounds; Student Affairs and Athletics;
Educational Policy; Advancement and Communications; Audit,
Compliance, and Risk; The University of Virginia’s College at
Wise; Medical Center Operating Board; and Diversity and
Inclusion. The (current) special committees are Governance and
Research. (Special committees must be continued annually by a
vote of the Board.)
DISCUSSION: The following are suggestions for structuring
committees and committee meetings:

Committee meetings are consecutive in order to allow
Visitors to educate themselves about all aspects of the
University, and Visitors are invited to attend all of the
committee meetings.

Decouple crisis communications from Advancement:
Communications will report on branding matters in the
Advancement Committee; crisis communications will be
addressed by the Executive Committee.

Executive Committee: Operate as a true executive and
governance committee, meeting off cycle when necessary to
conduct Board business. The governance part of duties is
now statutory. The Executive Committee is by statute
seven members, with the rector as chair and the vice
rector as vice chair. Other (limited to five) members of
the Executive Committee are elected by the Board at the
Annual Meeting in September.
11

Add Diversity and Inclusion matters to the Executive
Committee because these important issues span all areas
of the University.

Encompass organizational excellence and research funding
in the Finance Committee charge.

Focus Buildings and Grounds meetings on land use
planning, acquisition, and development; use of space; and
siting, design, and development of buildings.

Combine the committees on Student Affairs and Athletics
and Educational Policy to create a new Academic and
Student Life Committee which encompasses athletics,
culture and safety, educational policy, and research
programs for a broader perspective on academic life both
within the classroom and outside the classroom.

Medical Center Operating Board (MCOB): Schedule meetings
for six times a year and/or for six hours per meeting.
Two alternatives: 1. Hold MCOB meetings separately from
the regular meeting schedule; or 2. Add two longer (full
day) meetings per year separate from the regular meeting
schedule and keep half-day MCOB meetings on the first
morning of each regular meeting. For instance, add an
October and March full day MCOB meeting to the yearly
schedule. These schedule changes do not affect the
committee charge.

One arrangement we have used fairly effectively is having
two Visitors oversee an area of concentration, and so we
are suggesting that committee chairs designate two
Visitors to oversee each area of committee concentration
and consider if there are additional areas of committee
concentration that would benefit from that oversight
arrangement. This gives the designated Visitors the
opportunity to learn in an in-depth manner an area of
focus and ensures that a given area of focus benefits
from the close involvement of two Visitors. These areas
of concentration may change over time.
This proposal would reduce the number of committees from 12
to eight. The new structure would be:

Advancement—suggested areas of concentration:
o Bicentennial
o Capital Campaign
12
o Communications/Branding

Audit, Compliance, and Risk

Executive—suggested areas of concentration:
o Advocacy
o Diversity and Inclusion
o Communications/Crisis
o Governance

Finance—suggested areas of concentration:
o Organizational Excellence
o Research Funding

Buildings and Grounds

Academic and Student Life—suggested areas of
concentration:
o Athletics
o Culture and Safety
o Educational policy
o Research programs

The University of Virginia’s College at Wise

Medical Center Operating Board
A chart of the proposed changes and how they relate to the
original structure can be found in Attachment A. Attachment B
contains revised charges for the committees.
13
ATTACHMENTS
ATTACHMENT A
ATTACHMENT B
BOARD COMMITTEE CHARGES — PROPOSAL
EXECUTIVE COMMITTEE [revised sections underlined] — At each
Annual Meeting the Board shall elect from among its membership
an Executive Committee composed of seven members. These seven
members shall consist of the Rector, who shall serve as chair,
the Vice Rector, who shall serve as vice chair, and five
Visitors to be elected by the Board. Nominations for these five
positions on the Executive Committee may be made by any
Visitor, and if there are more than five nominations, a vote
shall be taken, and the results shall be announced jointly by
the Rector and the Secretary. Any vacancy on the Executive
Committee shall be filled for the unexpired term at the next
regular meeting of the Board and by vote if there is more than
one nomination.
The Executive Committee shall meet upon the call of the
Rector. It shall consider all matters referred to it by the
Rector, the Vice Rector, or the President and shall, in the
interim between meetings of the Board, be vested with the
powers and authority of the full Board and shall take such
action on all matters that may be referred to it as in its
judgment is required. All such actions taken by the Executive
Committee in the interim between meetings of the Board shall
require a two-thirds vote of the whole number of committee
members, and their actions shall be reported to the Board at
the next regular meeting and shall, if confirmation is required,
be confirmed and approved by the Board at that time.
In addition to the above, the Executive Committee shall
organize the working processes of the Board and recommend best
practices for governance to the Board. More specifically, the
Executive Committee shall:
1. Develop and recommend to the Board a statement of
governance setting out the Board’s role;
2. Periodically review the Board’s bylaws and recommend
amendments;
3. Provide advice to the Board on committee structure,
appointments and meetings;
4. Develop an orientation and continuing education
process for Visitors that includes training on the
Virginia Freedom of Information Act;
5. Create, monitor, oversee, and review compliance with a
code of ethics for Visitors; and
6. Develop a set of qualifications and competencies for
membership on the Board for approval by the Board and
recommendation to the Governor.
1|P age
ATTACHMENT B
As part of its responsibilities, the Executive Committee
shall work with the President to encourage and support an
atmosphere at the University that ensures that diverse members
of the University of Virginia and Charlottesville communities
are treated equally and fairly.
This is essential to creating
an educational experience for students to prepare them for
productive and responsible citizenship in the world beyond the
University community.
This responsibility includes encouraging
and supporting the attraction and retention of a diverse group
of students, faculty, and staff.
“Diverse” includes race and
ethnicity, age, gender, disability status, sexual orientation,
religion and national origin, socio-economic status, and other
aspects of individual experience and identity.
FINANCE COMMITTEE [revised sections underlined] — The Finance
Committee shall be responsible in all matters relating to the
University’s financial affairs and business operations. It shall
review and approve the annual budget and the setting of tuition
rates,
student
fees,
and
other
student
charges
for
recommendation to the Board. On behalf of the Board, it shall
establish metrics and monitor programs for organizational
excellence, approve the investment of endowment and other funds
and the purchase of real and personal property, and it shall
make progress reports to the Board on its actions.
The committee shall maintain liaison with the University of
Virginia Investment Management Company, a nonprofit, nonstock
corporation organized under Virginia law to provide investment
and investment management and related services to the University
of Virginia, and shall monitor and review periodically the
performance of the Company.
The Finance Committee shall be responsible for all matters
relating to funding research programs and partnerships of the
University.
The scope shall include all forms of research
funding: external and internal sources of research support,
startup packages for faculty, and commercialization activities
and translational research.
The committee may offer guidance
on such issues as strategic investments in research, the
infrastructure for research, strategic partnerships that enhance
research capability and impact, and intellectual property
policies.
BUILDINGS AND GROUNDS COMMITTEE — The Buildings and Grounds
Committee shall have responsibility in matters relating to land
use and the physical plant. It shall be responsible for land use
planning and acquisition policy as well as exercising oversight
over the use of space and the care, maintenance, and security of
2|P age
ATTACHMENT B
the University’s buildings and grounds including furnishings and
equipment; the selection of architects and engineers and the
siting, construction, and naming of new buildings; and such
other matters relating to the buildings and grounds of the
University as may come before it. On behalf of the Board, it
shall approve the siting and design of new buildings and shall
make progress reports to the Board on its actions.
ACADEMIC AND STUDENT LIFE COMMITTEE [combined Student Affairs
and Athletics and Educational Policy] - The Academic and Student
Life Committee shall have oversight of matters relating to
athletics, culture and safety, educational policy, and research
programs. The Committee shall oversee matters relating to
student conduct, residential and social life, extracurricular
activities, food services, health, and such other matters
relating to student affairs as may be brought to its attention;
and
athletic
policy
and
programs,
both
intramural
and
intercollegiate.
In exercising its responsibilities for educational policy
and research programs, the committee shall have responsibility
in all matters relating to educational and research policies and
programs except for those matters subject to the oversight of
the Medical Center Operating Board. The committee shall exercise
oversight over the proposal of new degrees and educational
programs by the President, the conditions affecting the
recruitment and retention of faculty members, the adequacy of
instructional and research facilities, and such other matters
relating to the educational policies and programs as may be
brought before it by the President or Provost or referred to it
by the Board.
AUDIT, COMPLIANCE, AND RISK COMMITTEE [no revisions] — The
Audit, Compliance, and Risk Committee shall have oversight
responsibility for internal audit, compliance, and enterprise
risk management programs for the academic and medical center
divisions, as it relates to financial, operational, compliance,
strategic, and reputational risks.
The committee shall have
direct access to internal and external auditors to assess
performance, the scope of audit activities, and the adequacy of
internal accounting controls.
The committee shall review, at
least annually, the institution’s risk governance framework
including the risk assessment and mitigation strategies.
The
committee also shall receive periodic reports on other such
audit, compliance, and risk matters from the State auditor,
senior management, and the institution’s internal audit,
3|P age
ATTACHMENT B
compliance, and enterprise risk management leaders.
leaders shall also have direct access to the board.
Such
ADVANCEMENT COMMITTEE - The Advancement Committee shall have
responsibility
in
all
matters
pertaining
to
University
development, alumni affairs, and public communications. This
responsibility shall include the oversight of University capital
campaigns, branding efforts, and all other programs that promote
the University publicly and with alumni and friends. As part of
this responsibility, the committee’s oversight will include the
University-related foundations and their activities to raise
funds on behalf of the University.
THE COMMITTEE ON THE UNIVERSITY OF VIRGINIA’S COLLEGE AT WISE
[not revised] — The Committee on The University of Virginia’s
College at Wise is charged with the oversight of the College and
the advancement of its mission and with bringing its needs and
concerns to the attention of the Board of Visitors. The
committee will assist the Chancellor in carrying out the
Chancellor’s duties and will further the goals of The University
of Virginia’s College at Wise.
THE MEDICAL CENTER OPERATING BOARD [not revised] — The Medical
Center Operating Board shall be the governing board of the
Medical Center and the Transitional Care Hospital for Joint
Commission on Accreditation of Hospital Organization purposes,
responsible to oversee and direct the operations of the Medical
Center and the Transitional Care Hospital as delegated by the
Board of Visitors.
The Rector shall serve as a voting member, and he shall
appoint five other members of the Board of Visitors, including
the chair, to serve as voting members of the Medical Center
Operating Board; one of these members shall be the chair of the
Finance Committee and one of these members shall be a physician
with administrative and clinical experience in an academic
medical center. The Board of Visitors may appoint no more than
six public non-voting members of the Medical Center Operating
Board to serve for initial terms not to exceed four years. The
President of the University, the Executive Vice President and
Provost of the University, the Executive Vice President and
Chief Operating Officer of the University, the Executive Vice
President for Health Affairs, the Chief Executive Officer of the
Medical Center, the Dean of the School of Medicine, the Dean of
the School of Nursing, and the President of the Clinical Staff
of the Medical Center shall serve as non-voting advisory
members.
4|P age
ATTACHMENT C
CODE OF VIRGINIA
§ 23-9.2:4.1. Faculty representatives to the State Board for Community
Colleges, local community college boards, and boards of visitors.
A. The State Board for Community Colleges, local community college boards, and the
boards of visitors of any four-year state institution of higher education may appoint one
or more nonvoting, advisory faculty representatives to their respective boards. In the
case of local community college boards and boards of visitors, the representatives
appointed by the boards shall be chosen from individuals elected by the faculty or the
institution's faculty senate or other equivalent group of the relevant institution. In the
case of the State Board for Community Colleges, representatives appointed by the Board
shall be chosen from individuals elected by the Chancellor's Faculty Advisory
Committee. Such representatives shall be appointed to serve terms of not less than one
12-month period, which shall be coterminous with the institution's fiscal year, or for
such terms as may be mutually agreed to by the State Board for Community Colleges
and the Chancellor's Faculty Advisory Committee, or by the local community college
board or the board of visitors, as the case may be, and the institution's faculty senate or
other equivalent group.
B. Nothing in this section shall prohibit the State Board for Community Colleges, local
community college boards, or any boards of visitors from excluding such representatives
from discussions of faculty grievances, faculty or staff disciplinary matters, or salaries,
or other matters, at the discretion of the relevant board.
2004, cc. 499, 519.